Abuhamdan v. Blyth, Inc.

9 F. Supp. 3d 175, 2014 WL 1289251, 2014 U.S. Dist. LEXIS 44481
CourtDistrict Court, D. Connecticut
DecidedMarch 31, 2014
DocketNo. 3:12cv1597 (MPS)
StatusPublished
Cited by15 cases

This text of 9 F. Supp. 3d 175 (Abuhamdan v. Blyth, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Abuhamdan v. Blyth, Inc., 9 F. Supp. 3d 175, 2014 WL 1289251, 2014 U.S. Dist. LEXIS 44481 (D. Conn. 2014).

Opinion

RULING ON MOTION TO DISMISS

MICHAEL P. SHEA, District Judge.

The Plaintiffs bring this class action on behalf of all persons who purchased common stock of Blyth, Inc. (“Blyth”), between January 13, 2012 and November 6, 2012, alleging violations of the Securities Exchange Act of 1934 (the “Exchange Act”). The Plaintiffs bring their claims under Sections 10(b) and 20(a) of the Exchange Act, 15 U.S.C. §§ 78j(b) and 78t(a), respectively, and Rule 10b-5, 17 C.F.R. § 240.10b-5, promulgated by the Securities and Exchange Commission (“SEC”) pursuant to Section 10(b). The Defendants — Blyth, Robert Goergen (“Goer-gen”), Robert Barghaus (“Barghaus”), Vi-Salus Holdings, LLC and ViSalus, Inc. (collectively “ViSalus”), and Nick Sarnicola (“Sarnicola”) — have moved to dismiss all of the claims in the Plaintiffs’ Second Amended Complaint (the “Complaint”).1

[180]*180On August 4, 2008, Blyth entered into an agreement to purchase ViSalus through a series of four investments to be made over a period of approximately four years. Plaintiffs’ core claim is that Goergen and Sarnicola engaged in a deceptive scheme, or made misleading statements that omitted material information about ViSalus, for the purpose of artificially inflating ViSa-lus’s price at the fourth and final step of the purchase, and that this conduct harmed purchasers of Blyth stock. The Complaint alleges that, because they owned substantial interests in ViSalus, Goergen and Sarnicola stood to benefit handsomely from selling their ViSalus shares at an artificially inflated price.

Plaintiffs’ omissions claim is that Defendants made a series of positive statements to the marketplace about ViSalus’s business, which was a key driver of Blyth’s business, and that those statements misled Blyth investors because they omitted material information about ViSalus that would have disclosed that its dramatic growth during 2011 and the first half of 2012 was “illusory” and would be “short-lived.” In particular, the Complaint alleges that Defendants knew, but failed to disclose, that ViSalus’s growth was driven by the recruitment of “transient” salespersons (referred to as “promoters”) rather than- sales to genuine consumers, and that the “extraordinarily high” turnover rate among promoters rendered ViSalus’s growth and business model unsustainable. Plaintiffs argue that Blyth’s stock traded at an artificially high price as a result, and that when the true nature of ViSalus’s growth was revealed to the market, the price of Blyth stock declined precipitously.

Plaintiffs’ omissions theory cannot withstand dismissal, however, both because it fails to plead facts showing that Defendants made a misleading statement and because it fails to plead the element of loss causation. The failure to plead a misleading statement can be broken into three independent problems: (1) most of the statements upon which Plaintiffs’ omissions theory is based are not actionable, (2) Defendants had no duty to disclose the omitted information in light of what had been disclosed to the market, and (3) the Complaint fails to plead the omitted information with sufficient particularity. The Complaint fails to plead loss causation because it is devoid of factual allegations showing that the drop in Blyth’s stock price was caused by either a corrective disclosure or the materialization of a concealed (as opposed to a disclosed) risk.

Plaintiffs’ separate claim for a deceptive scheme under Rule 10b-5(a) and (c) must also be dismissed because it fails to plead inherently deceptive conduct and, like the omissions claim, fails to plead a plausible theory of loss causation. The deceptive scheme claim is premised upon the allegation that Sarnicola, a co-founder of ViSa-lus, recruited teams of promoters from other companies knowing that they would be at ViSalus only for a short term. The problem is that the act .of recruiting salespersons from other companies is not inherently deceptive, and thus cannot form the [181]*181basis of a deceptive scheme claim. Further, the Complaint fails to plead the key allegation — that Sarnicola knew the recruited teams of promoters would be at ViSalus for a short term — with the requisite particularity, and the deceptive scheme claim also suffers from the same problem with respect to loss causation as the omissions claim.

Plaintiffs’ other claims are derivative of the omissions and deceptive scheme claims and thus must be dismissed as well. Defendants’ motion to dismiss is therefore GRANTED.

I. BACKGROUND

The following allegations are taken from the Complaint.

A. Blyth, ViSalus, and the MultiLevel Marketing Model

Blyth, which describes itself as “a direct to consumer business focused on the direct selling and direct marketing channels,” markets and sells a number of products, including weight management- products and decorative and functional household items. (Pis.’ Second Amended Complaint (“Compl.”) [Doc. # 71] at ¶ 2.) Goergen served as Blyth’s Chief Executive Officer and Chairman of the Board during the class period. (Id. ¶ 16.) Goergen owns 35% of Blyth’s shares and is Blyth’s largest single shareholder. (Id.) Barghaus is, and was throughout the class period, Blyth’s Vice President and Chief Financial Officer. (Id. ¶ 17.)

ViSalus, which was founded in 2005 and most of which was acquired by Blyth in a series of transactions alleged in the Complaint, describes itself as “one of the fastest growing direet-to-consumer, personal health product companies in North America.” (Id. ¶ 38.) ViSalus sells weight-management products, nutritional supplements, and energy drinks. (Id.) Sarnicola is a co-founder of ViSalus and its “Global Ambassador.” (Id. ¶ 22.) ViSalus operates its business through what is commonly known as “multi-level marketing,” a “business strategy whereby a company induces independent, non-salaried persons (‘promoters’) to both sell — and recruit other persons to sell — the company’s products by offering the promoters commissions on their own sales as well as the sales made by -persons they have recruited and by persons their recruits have also recruited.” (Id. ¶ 40.) The sales force recruited by a particular promoter, or by that promoter’s recruits, is referred to as that promoter’s “downline.” (Id.)

The Complaint alleges that, because of the nature of its multi-level marketing model, ViSalus “might be considered a pyramid scheme.” (Id. ¶ 64.) The Bureau of Consumer Protection of the Federal Trade Commission (“FTC”) has stated that “[n]ot all multilevel marketing plans are legitimate,” and that “[s]ome are pyramid schemes.” (Id. ¶ 65.) A multilevel marketing company is illegitimate, according to the FTC, “[i]f the money you make is based' on the number of people you recruit and your sales to them.” (Id. ¶ 41.) As the Complaint explains, “[i]f a company’s growth is based on recruitment, rather than sales to genuine consumers, most promoters will assuredly fail because such a model is intrinsically designed to fail as there are literally not enough people to make these companies profitable to most of those involved.” (Id.)

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Helo v. Sema4 Holdings Corp.
D. Connecticut, 2024
iMerchandise LLC v. TSDC, LLC
D. Connecticut, 2021
Labul v. XPO Logistics, Inc.
D. Connecticut, 2021
Singh v. Cigna Corp.
277 F. Supp. 3d 291 (D. Connecticut, 2017)
Federal Energy Regulatory Commission v. Maxim Power Corp.
196 F. Supp. 3d 181 (D. Massachusetts, 2016)
AG Funds, L.P. v. Sanofi
87 F. Supp. 3d 510 (S.D. New York, 2015)
Stratte-McClure v. Stanley
776 F.3d 94 (Second Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
9 F. Supp. 3d 175, 2014 WL 1289251, 2014 U.S. Dist. LEXIS 44481, Counsel Stack Legal Research, https://law.counselstack.com/opinion/abuhamdan-v-blyth-inc-ctd-2014.